The standard of care for newly diagnosed adults with glioblastoma, especially those with MGMT promoter methylated tumors, remains chemoradiation with temozolomide followed by 6 to 12 cycles of adjuvant temozolomide (72). The gene discussed is MGMT; the disease is glioblastoma.